annual operating profit:
-$3.94B+$294.00M(+6.94%)Summary
- As of today (May 21, 2025), MRNA annual operating income is -$3.94 billion, with the most recent change of +$294.00 million (+6.94%) on December 31, 2024.
- During the last 3 years, MRNA annual operating profit has fallen by -$17.24 billion (-129.67%).
- MRNA annual operating profit is now -129.67% below its all-time high of $13.30 billion, reached on December 31, 2021.
Performance
MRNA Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$1.05B+$196.00M(+15.73%)Summary
- As of today (May 21, 2025), MRNA quarterly operating income is -$1.05 billion, with the most recent change of +$196.00 million (+15.73%) on March 31, 2025.
- Over the past year, MRNA quarterly operating profit has increased by +$216.00 million (+17.06%).
- MRNA quarterly operating profit is now -119.41% below its all-time high of $5.41 billion, reached on December 31, 2021.
Performance
MRNA quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$3.73B+$216.00M(+5.48%)Summary
- As of today (May 21, 2025), MRNA TTM operating income is -$3.73 billion, with the most recent change of +$216.00 million (+5.48%) on March 31, 2025.
- Over the past year, MRNA TTM operating profit has increased by +$1.41 billion (+27.44%).
- MRNA TTM operating profit is now -122.94% below its all-time high of $16.26 billion, reached on March 31, 2022.
Performance
MRNA TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
MRNA Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.9% | +17.1% | +27.4% |
| 3 y3 years | -129.7% | -124.8% | -122.9% |
| 5 y5 years | -622.5% | -701.5% | -596.5% |
MRNA Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -129.7% | +6.9% | -124.8% | +47.8% | -122.9% | +27.4% |
| 5 y | 5-year | -129.7% | +6.9% | -119.4% | +47.8% | -122.9% | +27.4% |
| alltime | all time | -129.7% | +6.9% | -119.4% | +47.8% | -122.9% | +27.4% |
MRNA Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.05B(-15.7%) | -$3.73B(-5.5%) |
| Dec 2024 | -$3.94B(-6.9%) | -$1.25B(+1680.0%) | -$3.94B(+46.5%) |
| Sep 2024 | - | -$70.00M(-94.9%) | -$2.69B(-41.9%) |
| Jun 2024 | - | -$1.36B(+7.7%) | -$4.63B(-9.8%) |
| Mar 2024 | - | -$1.27B(<-9900.0%) | -$5.14B(+21.2%) |
| Dec 2023 | -$4.24B(-145.0%) | $6.00M(-100.3%) | -$4.24B(+59.1%) |
| Sep 2023 | - | -$2.01B(+7.8%) | -$2.67B(-619.5%) |
| Jun 2023 | - | -$1.87B(+410.1%) | $513.00M(-89.4%) |
| Mar 2023 | - | -$366.00M(-123.2%) | $4.83B(-48.8%) |
| Dec 2022 | $9.42B(-29.2%) | $1.58B(+35.5%) | $9.42B(-28.9%) |
| Sep 2022 | - | $1.17B(-52.3%) | $13.25B(-15.3%) |
| Jun 2022 | - | $2.45B(-42.1%) | $15.64B(-3.8%) |
| Mar 2022 | - | $4.23B(-21.9%) | $16.26B(+22.3%) |
| Dec 2021 | $13.30B(-1842.6%) | $5.41B(+52.1%) | $13.30B(+74.7%) |
| Sep 2021 | - | $3.56B(+16.2%) | $7.61B(+99.3%) |
| Jun 2021 | - | $3.06B(+141.9%) | $3.82B(+502.2%) |
| Mar 2021 | - | $1.27B(-560.4%) | $634.00M(-183.1%) |
| Dec 2020 | -$763.00M(+39.7%) | -$275.00M(+17.0%) | -$763.00M(+23.5%) |
| Sep 2020 | - | -$235.00M(+92.6%) | -$617.89M(+20.3%) |
| Jun 2020 | - | -$122.00M(-6.9%) | -$513.65M(-4.1%) |
| Mar 2020 | - | -$131.00M(+0.9%) | -$535.36M(-1.9%) |
| Dec 2019 | -$546.00M(+32.1%) | -$129.89M(-0.7%) | -$546.00M(-4.1%) |
| Sep 2019 | - | -$130.76M(-9.0%) | -$569.14M(+8.6%) |
| Jun 2019 | - | -$143.71M(+1.5%) | -$524.20M(+9.8%) |
| Mar 2019 | - | -$141.64M(-7.4%) | -$477.50M(+15.5%) |
| Dec 2018 | -$413.27M(+53.4%) | -$153.03M(+78.3%) | -$413.27M(+36.8%) |
| Sep 2018 | - | -$85.82M(-11.5%) | -$302.06M(+39.0%) |
| Jun 2018 | - | -$97.02M(+25.3%) | -$217.28M(+79.3%) |
| Mar 2018 | - | -$77.40M(+85.0%) | -$121.21M(+170.7%) |
| Dec 2017 | -$269.36M(+20.4%) | -$41.83M(+3937.5%) | -$44.78M(+1228.9%) |
| Sep 2017 | - | -$1.04M(+9.2%) | -$3.37M(+38.6%) |
| Jun 2017 | - | -$948.90K(-1.9%) | -$2.43M(+50.9%) |
| Mar 2017 | - | -$967.30K(+131.7%) | -$1.61M(+112.6%) |
| Dec 2016 | -$223.77M(+5509.7%) | - | - |
| Dec 2016 | - | -$417.40K(+327.2%) | -$757.70K(-21.1%) |
| Sep 2016 | - | -$97.70K(-23.9%) | -$960.30K(-49.3%) |
| Jun 2016 | - | -$128.40K(+12.4%) | -$1.89M(-32.0%) |
| Mar 2016 | - | -$114.20K(-81.6%) | -$2.79M(-30.1%) |
| Dec 2015 | -$3.99M(+13.3%) | -$620.00K(-39.9%) | -$3.99M(-1.5%) |
| Sep 2015 | - | -$1.03M(+1.0%) | -$4.05M(-12.4%) |
| Jun 2015 | - | -$1.02M(-22.3%) | -$4.62M(+8.2%) |
| Mar 2015 | - | -$1.31M(+93.7%) | -$4.27M(+21.4%) |
| Dec 2014 | -$3.52M(+864.4%) | -$679.00K(-57.7%) | -$3.52M(+24.9%) |
| Sep 2014 | - | -$1.61M(+139.5%) | -$2.82M(+159.2%) |
| Jun 2014 | - | -$671.00K(+19.2%) | -$1.09M(+80.6%) |
| Mar 2014 | - | -$563.00K(-2547.8%) | -$602.00K(+64.9%) |
| Dec 2013 | -$365.00K(-94.1%) | $23.00K(-81.5%) | -$365.00K(-78.2%) |
| Sep 2013 | - | $124.00K(-166.7%) | -$1.67M(-18.1%) |
| Jun 2013 | - | -$186.00K(-42.9%) | -$2.04M(-14.3%) |
| Mar 2013 | - | -$326.00K(-74.6%) | -$2.38M(-61.6%) |
| Dec 2012 | -$6.20M(-64.7%) | -$1.28M(+424.5%) | -$6.20M(-17.7%) |
| Sep 2012 | - | -$245.00K(-53.5%) | -$7.54M(-36.2%) |
| Jun 2012 | - | -$527.00K(-87.3%) | -$11.81M(-29.2%) |
| Mar 2012 | - | -$4.14M(+58.2%) | -$16.68M(-5.1%) |
| Dec 2011 | -$17.57M(-32.4%) | -$2.62M(-42.0%) | -$17.57M(-6.4%) |
| Sep 2011 | - | -$4.52M(-16.1%) | -$18.76M(-23.6%) |
| Jun 2011 | - | -$5.39M(+7.0%) | -$24.57M(-2.0%) |
| Mar 2011 | - | -$5.04M(+32.2%) | -$25.07M(-3.6%) |
| Dec 2010 | -$26.00M(+154.0%) | -$3.81M(-63.1%) | -$26.00M(-4.9%) |
| Sep 2010 | - | -$10.33M(+75.3%) | -$27.34M(+15.1%) |
| Jun 2010 | - | -$5.89M(-1.4%) | -$23.75M(-1.6%) |
| Mar 2010 | - | -$5.97M(+16.0%) | -$24.14M(+135.8%) |
| Dec 2009 | -$10.24M | -$5.15M(-23.5%) | -$10.24M(-40.3%) |
| Sep 2009 | - | -$6.73M(+7.2%) | -$17.14M(-15.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | -$6.28M(-179.2%) | -$20.18M(-28.3%) |
| Mar 2009 | - | $7.93M(-165.8%) | -$28.13M(-44.5%) |
| Dec 2008 | -$50.69M(-7.1%) | -$12.05M(+23.2%) | -$50.69M(-0.5%) |
| Sep 2008 | - | -$9.78M(-31.3%) | -$50.95M(-12.4%) |
| Jun 2008 | - | -$14.23M(-2.7%) | -$58.13M(+2.1%) |
| Mar 2008 | - | -$14.63M(+18.8%) | -$56.93M(+4.4%) |
| Dec 2007 | -$54.53M(+86.0%) | -$12.31M(-27.4%) | -$54.53M(+2.3%) |
| Sep 2007 | - | -$16.97M(+30.2%) | -$53.32M(+19.1%) |
| Jun 2007 | - | -$13.03M(+6.6%) | -$44.75M(+36.1%) |
| Mar 2007 | - | -$12.23M(+10.2%) | -$32.88M(+12.1%) |
| Dec 2006 | -$29.32M(-13.3%) | -$11.10M(+32.2%) | -$29.32M(+5.8%) |
| Sep 2006 | - | -$8.40M(+628.4%) | -$27.70M(-2.9%) |
| Jun 2006 | - | -$1.15M(-86.7%) | -$28.55M(-20.9%) |
| Mar 2006 | - | -$8.67M(-8.6%) | -$36.08M(+6.8%) |
| Dec 2005 | -$33.80M(+18.6%) | -$9.48M(+2.7%) | -$33.80M(+11.8%) |
| Sep 2005 | - | -$9.24M(+6.3%) | -$30.24M(+6.0%) |
| Jun 2005 | - | -$8.69M(+36.1%) | -$28.52M(+4.6%) |
| Mar 2005 | - | -$6.39M(+7.9%) | -$27.27M(-4.3%) |
| Dec 2004 | -$28.49M(+358.7%) | -$5.92M(-21.3%) | -$28.49M(-0.0%) |
| Sep 2004 | - | -$7.53M(+1.2%) | -$28.50M(+4.7%) |
| Jun 2004 | - | -$7.44M(-2.1%) | -$27.22M(+147.9%) |
| Mar 2004 | - | -$7.60M(+28.1%) | -$10.98M(+76.8%) |
| Dec 2003 | -$6.21M(-52.2%) | -$5.93M(-5.0%) | -$6.21M(+15.5%) |
| Sep 2003 | - | -$6.25M(-171.0%) | -$5.38M(+106.1%) |
| Jun 2003 | - | $8.80M(-410.7%) | -$2.61M(-79.9%) |
| Mar 2003 | - | -$2.83M(-44.5%) | -$12.96M(-0.2%) |
| Dec 2002 | -$12.99M(+36.0%) | -$5.10M(+46.6%) | -$12.99M(+18.3%) |
| Sep 2002 | - | -$3.48M(+124.1%) | -$10.98M(+16.9%) |
| Jun 2002 | - | -$1.55M(-45.8%) | -$9.40M(-6.1%) |
| Mar 2002 | - | -$2.86M(-7.4%) | -$10.01M(+4.8%) |
| Dec 2001 | -$9.55M(-7.6%) | -$3.09M(+63.2%) | -$9.55M(-5.9%) |
| Sep 2001 | - | -$1.89M(-12.4%) | -$10.15M(+0.5%) |
| Jun 2001 | - | -$2.16M(-10.0%) | -$10.11M(-2.5%) |
| Mar 2001 | - | -$2.40M(-35.0%) | -$10.36M(+0.3%) |
| Dec 2000 | -$10.34M(+9.3%) | -$3.69M(+99.9%) | -$10.34M(-2.4%) |
| Sep 2000 | - | -$1.85M(-23.5%) | -$10.59M(-1.1%) |
| Jun 2000 | - | -$2.42M(+1.8%) | -$10.71M(+7.2%) |
| Mar 2000 | - | -$2.38M(-39.9%) | -$9.99M(-0.2%) |
| Dec 1999 | -$9.45M(+301.9%) | -$3.95M(+101.5%) | -$10.02M(+17.6%) |
| Sep 1999 | - | -$1.96M(+15.4%) | -$8.51M(+24.3%) |
| Jun 1999 | - | -$1.70M(-29.2%) | -$6.85M(+28.0%) |
| Mar 1999 | - | -$2.40M(-2.1%) | -$5.35M(+69.8%) |
| Dec 1998 | -$2.35M(-60.8%) | -$2.45M(+717.3%) | -$3.15M(+1.7%) |
| Sep 1998 | - | -$300.00K(+50.0%) | -$3.10M(-31.1%) |
| Jun 1998 | - | -$200.00K(0.0%) | -$4.50M(-19.6%) |
| Mar 1998 | - | -$200.00K(-91.7%) | -$5.60M(-8.2%) |
| Dec 1997 | -$6.00M(+1100.0%) | -$2.40M(+41.2%) | -$6.10M(+64.9%) |
| Sep 1997 | - | -$1.70M(+30.8%) | -$3.70M(+85.0%) |
| Jun 1997 | - | -$1.30M(+85.7%) | -$2.00M(+300.0%) |
| Mar 1997 | - | -$700.00K(<-9900.0%) | -$500.00K(<-9900.0%) |
| Dec 1996 | -$500.00K(+400.0%) | - | - |
| Sep 1996 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 1996 | -$100.00K(0.0%) | $200.00K(+100.0%) | -$100.00K(-66.7%) |
| Mar 1996 | - | $100.00K(-133.3%) | -$300.00K(-25.0%) |
| Dec 1995 | - | -$300.00K(+200.0%) | -$400.00K(+100.0%) |
| Sep 1995 | - | -$100.00K(<-9900.0%) | -$200.00K(<-9900.0%) |
| Jun 1995 | -$100.00K(-150.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1995 | - | $0.00(-100.0%) | $100.00K(>+9900.0%) |
| Dec 1994 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
| Sep 1994 | - | $100.00K(0.0%) | $200.00K(0.0%) |
| Jun 1994 | $200.00K | $100.00K(-200.0%) | $200.00K(+100.0%) |
| Mar 1994 | - | -$100.00K(-200.0%) | $100.00K(-50.0%) |
| Dec 1993 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna annual operating income?
- What is the all time high annual operating profit for Moderna?
- What is Moderna annual operating profit year-on-year change?
- What is Moderna quarterly operating income?
- What is the all time high quarterly operating profit for Moderna?
- What is Moderna quarterly operating profit year-on-year change?
- What is Moderna TTM operating income?
- What is the all time high TTM operating profit for Moderna?
- What is Moderna TTM operating profit year-on-year change?
What is Moderna annual operating income?
The current annual operating profit of MRNA is -$3.94B
What is the all time high annual operating profit for Moderna?
Moderna all-time high annual operating income is $13.30B
What is Moderna annual operating profit year-on-year change?
Over the past year, MRNA annual operating income has changed by +$294.00M (+6.94%)
What is Moderna quarterly operating income?
The current quarterly operating profit of MRNA is -$1.05B
What is the all time high quarterly operating profit for Moderna?
Moderna all-time high quarterly operating income is $5.41B
What is Moderna quarterly operating profit year-on-year change?
Over the past year, MRNA quarterly operating income has changed by +$216.00M (+17.06%)
What is Moderna TTM operating income?
The current TTM operating profit of MRNA is -$3.73B
What is the all time high TTM operating profit for Moderna?
Moderna all-time high TTM operating income is $16.26B
What is Moderna TTM operating profit year-on-year change?
Over the past year, MRNA TTM operating income has changed by +$1.41B (+27.44%)